Presarcopenia and its Impact on Disability in Female Patients With Rheumatoid Arthritis

ALKAN MELİKOĞLU, Meltem

Presarcopenia and its Impact on Disability in Female Patients With Rheumatoid Arthritis

Meltem ALKAN MELİKOĞLU (Department of Physical Medicine and Rehabilitation, Division of Rheumatology, Medical Faculty of Atatürk University, Erzurum, Turkey)

Archives of Rheumatology

2 1

Yıl: 2017 Cilt: 32 Sayı: 1 Sayfa Aralığı: 53 - 59 Metin Dili: İngilizce İndeks Tarihi: 29-07-2022

Presarcopenia and its Impact on Disability in Female Patients With Rheumatoid Arthritis

Öz:

Objectives: This cross-sectional pilot study aims to investigate presarcopenia in female patients with rheumatoid arthritis (RA) and to evaluate its relationship to the disability assessment.Patients and methods: Forty female patients with RA (mean age 48.3±8.3; range 31 to 66 years) and 40 healthy controls (mean age 46.2±6.9; range 31 to 58 years) matched for age, sex, and body mass index were included. Pain, morning stiffness duration, disease activity score, erythrocyte sedimentation rate, C-reactive protein, and Health Assessment Questionnaire (HAQ) were evaluated. Body compositions were assessed with whole body dual energy X-ray absorptiometry. The appendicular skeletal muscle mass and skeletal muscle mass index (SMI) of RA patients were compared to the controls and possible correlations between SMI, disease characteristics, and HAQ score were investigated.Results: The body mass index values and percentages of obese, overweight, and healthy weight subjects were similar in the patient and control groups. However, appendicular skeletal muscle mass and SMI calculations were significantly lower, and the percentage of presarcopenia was significantly higher in patients with RA (20%) than controls (7%) (p<0.05). Although there was no significant correlation between SMI and other parameters, a significant negative correlation was determined between SMI and HAQ score in patients with RA (p<0.05).Conclusion: We demonstrated lower SMI values and higher presarcopenia ratios in patients with RA than healthy controls. Independent from other disease characteristics, the inverse correlation between SMI and HAQ scores may contribute to understanding of the impact of the process on patient disability.

Anahtar Kelime:

Konular: Romatoloji

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık

1. Muscaritoli M, Anker SD, Argilés J, Aversa Z, Bauer JM, Biolo G, et al. Consensus definition of sarcopenia, cachexia and pre-cachexia: joint document elaborated by Special Interest Groups (SIG) "cachexia-anorexia in chronic wasting diseases" and "nutrition in geriatrics". Clin Nutr 2010;29:154-9.
2. Cruz-Jentoft AJ, Baeyens JP, Bauer JM, Boirie Y, Cederholm T, Landi F, et al. Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People. Age Ageing 2010;39:412-23.
3. Han DS, Chang KV, Li CM, Lin YH, Kao TW, Tsai KS, et al. Skeletal muscle mass adjusted by height correlated better with muscular functions than that adjusted by body weight in defining sarcopenia. Sci Rep 2016;6:19457.
4. Phillips SM. Nutritional supplements in support of resistance exercise to counter age-related sarcopenia. Adv Nutr 2015;6:452-60.
5. Dao HH, Do QT, Sakamoto J. Abnormal body composition phenotypes in Vietnamese women with early rheumatoid arthritis. Rheumatology (Oxford) 2011;50:1250-8.
6. Baker JF, Long J, Ibrahim S, Leonard MB, Katz P. Are men at greater risk of lean mass deficits in rheumatoid arthritis? Arthritis Care Res (Hoboken) 2015;67:112-9.
7. Prevoo ML, van 't Hof MA, Kuper HH, van Leeuwen MA, van de Putte LB, van Riel PL. Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 1995;38:44-8.
8. Wolfe F, Kleinheksel SM, Cathey MA, Hawley DJ, Spitz PW, Fries JF. The clinical value of the Stanford Health Assessment Questionnaire Functional Disability Index in patients with rheumatoid arthritis. J Rheumatol 1988;15:1480-8. 9. Küçükdeveci AA, Sahin H, Ataman S, Griffiths B, Tennant A. Issues in cross-cultural validity: example from the adaptation, reliability, and validity testing of a Turkish version of the Stanford Health Assessment Questionnaire. Arthritis Rheum 2004;51:14-9.
10. Pahor M, Manini T, Cesari M. Sarcopenia: clinical evaluation, biological markers and other evaluation tools. J Nutr Health Aging 2009;13:724-8.
11. Baumgartner RN, Koehler KM, Gallagher D, Romero L, Heymsfield SB, Ross RR, et al. Epidemiology of sarcopenia among the elderly in New Mexico. Am J Epidemiol 1998;147:755-63.
12. Gallagher D, Visser M, De Meersman RE, Sepúlveda D, Baumgartner RN, Pierson RN, et al. Appendicular skeletal muscle mass: effects of age, gender, and ethnicity. J Appl Physiol (1985) 1997;83:229-39.
13. Tankó LB, Movsesyan L, Mouritzen U, Christiansen C, Svendsen OL. Appendicular lean tissue mass and the prevalence of sarcopenia among healthy women. Metabolism 2002;51:69-74.
14. Ferraz-Amaro I, Delgado-Frias E, HernandezHernandez V, Muniz JR, Gonzalez-Diaz A, RodriguezBethencourt AG, et al. Abdominal Adiposity and Body Composition in Rheumatoid Arthritis: realtion with disease characteristics in a case control study. Arthritis Rheum 2013;65:577-8.
15. Teixeira Vde O, Filippin LI, Xavier RM. Mechanisms of muscle wasting in sarcopenia. Rev Bras Reumatol 2012;52:252-9.
16. Giles JT, Ling SM, Ferrucci L, Bartlett SJ, Andersen RE, Towns M, et al. Abnormal body composition phenotypes in older rheumatoid arthritis patients: association with disease characteristics and pharmacotherapies. Arthritis Rheum 2008;59:807-15.
17. Book C, Karlsson MK, Akesson K, Jacobsson LT. Early rheumatoid arthritis and body composition. Rheumatology (Oxford) 2009;48:1128-32.
18. Gamboa-Cardenas RV, Ugarte-Gil MF, No riega E, Medina-Chinchon M, Zevallos-Miranda F, CuchoVenegas JM, et al. Lean body mass (LBM) distribution negatively impacts on health related quality of life (HRQoL) in patients with rheumatoid arthritis (RA). Arthritis and Rheum 2013;65:181.
19. Summers GD, Deighton CM, Rennie MJ, Booth AH. Rheumatoid cachexia: a clinical perspective. Rheumatology (Oxford) 2008;47(8):1124-31.
20. Bianchi G, Rossi V, Muscari A, Magalotti D, Zoli M. Physical activity is negatively associated with the metabolic syndrome in the elderly. QJM 2008;101:713-21.
21. Guralnik JM, Fried LP, Salive ME. Disability as a public health outcome in the aging population. Annu Rev Public Health 1996;17:25-46.
22. Cawthon PM, Marshall LM, Michael Y, Dam TT, Ensrud KE, Barrett-Connor E, et al. Frailty in older men: prevalence, progression, and relationship with mortality. J Am Geriatr Soc 2007;55:1216-23.
23. Lauretani F, Russo CR, Bandinelli S, Bartali B, Cavazzini C, Di Iorio A, et al. Age-associated changes in skeletal muscles and their effect on mobility: an operational diagnosis of sarcopenia. J Appl Physiol (1985) 2003;95:1851-60.
24. Rolland Y, Czerwinski S, Abellan Van Kan G, Morley JE, Cesari M, Onder G, et al. Sarcopenia: its assessment, etiology, pathogenesis, consequences and future perspectives. J Nutr Health Aging 2008;12:433-50.
25. Topinková E. Aging, disability and frailty. Ann Nutr Metab 2008;52 Suppl 1:6-11.

APA	ALKAN MELİKOĞLU M (2017). Presarcopenia and its Impact on Disability in Female Patients With Rheumatoid Arthritis. , 53 - 59.
Chicago	ALKAN MELİKOĞLU Meltem Presarcopenia and its Impact on Disability in Female Patients With Rheumatoid Arthritis. (2017): 53 - 59.
MLA	ALKAN MELİKOĞLU Meltem Presarcopenia and its Impact on Disability in Female Patients With Rheumatoid Arthritis. , 2017, ss.53 - 59.
AMA	ALKAN MELİKOĞLU M Presarcopenia and its Impact on Disability in Female Patients With Rheumatoid Arthritis. . 2017; 53 - 59.
Vancouver	ALKAN MELİKOĞLU M Presarcopenia and its Impact on Disability in Female Patients With Rheumatoid Arthritis. . 2017; 53 - 59.
IEEE	ALKAN MELİKOĞLU M "Presarcopenia and its Impact on Disability in Female Patients With Rheumatoid Arthritis." , ss.53 - 59, 2017.
ISNAD	ALKAN MELİKOĞLU, Meltem. "Presarcopenia and its Impact on Disability in Female Patients With Rheumatoid Arthritis". (2017), 53-59.

APA	ALKAN MELİKOĞLU M (2017). Presarcopenia and its Impact on Disability in Female Patients With Rheumatoid Arthritis. Archives of Rheumatology, 32(1), 53 - 59.
Chicago	ALKAN MELİKOĞLU Meltem Presarcopenia and its Impact on Disability in Female Patients With Rheumatoid Arthritis. Archives of Rheumatology 32, no.1 (2017): 53 - 59.
MLA	ALKAN MELİKOĞLU Meltem Presarcopenia and its Impact on Disability in Female Patients With Rheumatoid Arthritis. Archives of Rheumatology, vol.32, no.1, 2017, ss.53 - 59.
AMA	ALKAN MELİKOĞLU M Presarcopenia and its Impact on Disability in Female Patients With Rheumatoid Arthritis. Archives of Rheumatology. 2017; 32(1): 53 - 59.
Vancouver	ALKAN MELİKOĞLU M Presarcopenia and its Impact on Disability in Female Patients With Rheumatoid Arthritis. Archives of Rheumatology. 2017; 32(1): 53 - 59.
IEEE	ALKAN MELİKOĞLU M "Presarcopenia and its Impact on Disability in Female Patients With Rheumatoid Arthritis." Archives of Rheumatology, 32, ss.53 - 59, 2017.
ISNAD	ALKAN MELİKOĞLU, Meltem. "Presarcopenia and its Impact on Disability in Female Patients With Rheumatoid Arthritis". Archives of Rheumatology 32/1 (2017), 53-59.